These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 12028980)

  • 1. Hemorrhagic Shock Associated with a Subcutaneous Insulin Pump Catheter: First Time Reported Side Effect.
    Vaduva P; Duntze C; Guenego A; Cocquerel N; Guilhem I
    Diabetes Technol Ther; 2024 Apr; 26(4):276-278. PubMed ID: 38156960
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural Ensemble of the Insulin Monomer.
    Busto-Moner L; Feng CJ; Antoszewski A; Tokmakoff A; Dinner AR
    Biochemistry; 2021 Oct; 60(42):3125-3136. PubMed ID: 34637307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes.
    Liu BL; Yin GP; Li FF; Hu Y; Wu JD; Chen MY; Ye L; Su XF; Ma JH
    Int J Endocrinol; 2018; 2018():2087960. PubMed ID: 29780415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of infusion set function: steel versus teflon.
    Patel PJ; Benasi K; Ferrari G; Evans MG; Shanmugham S; Wilson DM; Buckingham BA
    Diabetes Technol Ther; 2014 Jan; 16(1):15-9. PubMed ID: 24090124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin fibrillation and protein design: topological resistance of single-chain analogs to thermal degradation with application to a pump reservoir.
    Phillips NB; Whittaker J; Ismail-Beigi F; Weiss MA
    J Diabetes Sci Technol; 2012 Mar; 6(2):277-88. PubMed ID: 22538136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Achilles' heel in an amyloidogenic protein and its repair: insulin fibrillation and therapeutic design.
    Yang Y; Petkova A; Huang K; Xu B; Hua QX; Ye IJ; Chu YC; Hu SQ; Phillips NB; Whittaker J; Ismail-Beigi F; Mackin RB; Katsoyannis PG; Tycko R; Weiss MA
    J Biol Chem; 2010 Apr; 285(14):10806-21. PubMed ID: 20106984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory-based non-clinical comparison of occlusion rates using three rapid-acting insulin analogs in continuous subcutaneous insulin infusion catheters using low flow rates.
    Kerr D; Morton J; Whately-Smith C; Everett J; Begley JP
    J Diabetes Sci Technol; 2008 May; 2(3):450-5. PubMed ID: 19885209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of humalog insulin by reversed-phase high-performance liquid chromatography.
    Munsick C; Murray R; Dziubla T; Lowman AM; Joseph JI; Torjman MC
    J Diabetes Sci Technol; 2007 Jul; 1(4):603-7. PubMed ID: 19885125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic decompensation in pump users due to lispro insulin precipitation.
    Wolpert HA; Faradji RN; Bonner-Weir S; Lipes MA
    BMJ; 2002 May; 324(7348):1253. PubMed ID: 12028980
    [No Abstract]   [Full Text] [Related]  

  • 12. A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications?
    Ampudia-Blasco FJ; Hasbum B; Carmena R
    Diabetes Care; 2003 Mar; 26(3):953-4. PubMed ID: 12610070
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause?
    Griffin ME; Feder A; Tamborlane WV
    Diabetes Care; 2001 Jan; 24(1):174. PubMed ID: 11194227
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitiligo associated with subcutaneous insulin lispro infusion in type 1 diabetes.
    Burge MR; Carey JD
    Diabetes Care; 2004 Jan; 27(1):275-6. PubMed ID: 14694005
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of lipoatrophy with Lispro insulin without insulin pump therapy.
    Arranz A; Andia V; López-Guzmán A
    Diabetes Care; 2004 Feb; 27(2):625-6. PubMed ID: 14747261
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.